scispace - formally typeset
A

Anna Kirstein

Researcher at Leipzig University

Publications -  18
Citations -  57

Anna Kirstein is an academic researcher from Leipzig University. The author has contributed to research in topics: PTEN & Medicine. The author has an hindex of 2, co-authored 10 publications receiving 16 citations.

Papers
More filters
Journal ArticleDOI

Obesity-An Update on the Basic Pathophysiology and Review of Recent Therapeutic Advances.

TL;DR: In this paper, the authors reviewed the pathophysiology and pharmacotherapy of obesity including intersection points to the new generation of antidiabetic drugs and provided insight into the effectiveness of currently approved anti-obesity drugs and other therapeutic avenues that can be explored.
Journal ArticleDOI

The Novel Phosphatidylinositol-3-Kinase (PI3K) Inhibitor Alpelisib Effectively Inhibits Growth of PTEN-Haploinsufficient Lipoma Cells

TL;DR: Since alpelisib was well tolerated in first clinical trials, this drug alone or in combination with rapamycin is a potential new treatment option for PHTS-related adipose tissue overgrowth.
Journal ArticleDOI

A new human adipocyte model with PTEN haploinsufficiency

TL;DR: It was found that both cellular life span and the capacity for adipocyte differentiation as well as adipocyte-specific functions were preserved in LipPD1 and comparable to SGBS adipocytes.
Journal ArticleDOI

PTEN regulates adipose progenitor cell growth, differentiation, and replicative aging.

TL;DR: In this article, the role of PTEN in adipose tissue development was investigated and RNA-Seq of control and PTEN knockdown APCs was performed. And the results provided evidence that PTEN is involved in the regulation of APC proliferation, differentiation, and senescence.
Posted ContentDOI

PTEN regulates adipocyte progenitor growth, differentiation and replicative aging

TL;DR: In this article, the role of PTEN in adipose tissue development was investigated and RNA sequencing of control and PTEN knockdown APCs was performed and it was shown that reducing PTEN levels using siRNA or CRISPR leads to an enhanced proliferation and differentiation of APCs.